Academic Bibliography

 Search 200 years of publications by Ghent University researchers.
Advanced search
1 file | 298.82 KB
Add to list
  1. Search results
  2. Medication-overuse headache in patien...

Medication-overuse headache in patients with cluster headache

Koen Paemeleire (UGent) , A Bahra, Stefan Evers, MS Matharu and Peter J Goadsby
(2006) NEUROLOGY. 67(1). p.109-113
Author
Organization
Abstract
Objective: Medication-overuse headache (MOH) in cluster headache (CH) patients is incompletely described, perhaps because of the relatively low prevalence of CH. Methods: The authors describe a retrospective series of 17 patients (13 men, 4 women) with CH who developed MOH in association with overuse of a wide range of monotherapies or varying combinations of simple analgesics (n = 9), caffeine (n = 1), opioids (n = 10), ergotamine (n = 3), and triptans (n = 14). The series includes both episodic (n = 7) and chronic (n = 10) CH patients. Results: A specific triptan-overuse headache diagnosis was made in 3 patients, an opioid-overuse headache diagnosis was made in 1 patient, and an ergotamine-overuse headache diagnosis was made in 1 patient. In approximately half of the patients (n = 8), the MOH phenotype was a bilateral, dull, and featureless daily headache. In the other 9 patients, the MOH was characterized by at least one associated feature, most commonly nausea (n = 6), exacerbation with head movement (n = 5), or throbbing character of the pain (n = 5). The common denominator in 15 patients was a personal or family history, or both, of migraine. The 2 other patients gave a family history of unspecified headaches. Medication withdrawal was attempted and successful in 13 patients. Conclusions: Medication-overuse headache is a previously underrecognized and treatable problem associated with cluster headache (CH). CH patients should be carefully monitored, especially those with a personal or family history of migraine.
Keywords
SUBCUTANEOUS SUMATRIPTAN, HEMICRANIA CONTINUA, MIGRAINE, PREVALENCE, ERGOTAMINE, MANAGEMENT, SYMPTOMS, FEATURES, DISEASE, ONSET

Downloads

  • Download
    (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 298.82 KB

Citation

Please use this url to cite or link to this publication:

MLA
Paemeleire, Koen, et al. “Medication-Overuse Headache in Patients with Cluster Headache.” NEUROLOGY, vol. 67, no. 1, 2006, pp. 109–13, doi:10.1212/01.wnl.0000223332.35936.6e.
APA
Paemeleire, K., Bahra, A., Evers, S., Matharu, M., & Goadsby, P. J. (2006). Medication-overuse headache in patients with cluster headache. NEUROLOGY, 67(1), 109–113. https://doi.org/10.1212/01.wnl.0000223332.35936.6e
Chicago author-date
Paemeleire, Koen, A Bahra, Stefan Evers, MS Matharu, and Peter J Goadsby. 2006. “Medication-Overuse Headache in Patients with Cluster Headache.” NEUROLOGY 67 (1): 109–13. https://doi.org/10.1212/01.wnl.0000223332.35936.6e.
Chicago author-date (all authors)
Paemeleire, Koen, A Bahra, Stefan Evers, MS Matharu, and Peter J Goadsby. 2006. “Medication-Overuse Headache in Patients with Cluster Headache.” NEUROLOGY 67 (1): 109–113. doi:10.1212/01.wnl.0000223332.35936.6e.
Vancouver
1.
Paemeleire K, Bahra A, Evers S, Matharu M, Goadsby PJ. Medication-overuse headache in patients with cluster headache. NEUROLOGY. 2006;67(1):109–13.
IEEE
[1]
K. Paemeleire, A. Bahra, S. Evers, M. Matharu, and P. J. Goadsby, “Medication-overuse headache in patients with cluster headache,” NEUROLOGY, vol. 67, no. 1, pp. 109–113, 2006.
@article{356114,
  abstract     = {{Objective: Medication-overuse headache (MOH) in cluster headache (CH) patients is incompletely described, perhaps because of the relatively low prevalence of CH. Methods: The authors describe a retrospective series of 17 patients (13 men, 4 women) with CH who developed MOH in association with overuse of a wide range of monotherapies or varying combinations of simple analgesics (n = 9), caffeine (n = 1), opioids (n = 10), ergotamine (n = 3), and triptans (n = 14). The series includes both episodic (n = 7) and chronic (n = 10) CH patients. Results: A specific triptan-overuse headache diagnosis was made in 3 patients, an opioid-overuse headache diagnosis was made in 1 patient, and an ergotamine-overuse headache diagnosis was made in 1 patient. In approximately half of the patients (n = 8), the MOH phenotype was a bilateral, dull, and featureless daily headache. In the other 9 patients, the MOH was characterized by at least one associated feature, most commonly nausea (n = 6), exacerbation with head movement (n = 5), or throbbing character of the pain (n = 5). The common denominator in 15 patients was a personal or family history, or both, of migraine. The 2 other patients gave a family history of unspecified headaches. Medication withdrawal was attempted and successful in 13 patients. Conclusions: Medication-overuse headache is a previously underrecognized and treatable problem associated with cluster headache (CH). CH patients should be carefully monitored, especially those with a personal or family history of migraine.}},
  author       = {{Paemeleire, Koen and Bahra, A and Evers, Stefan and Matharu, MS and Goadsby, Peter J}},
  issn         = {{0028-3878}},
  journal      = {{NEUROLOGY}},
  keywords     = {{SUBCUTANEOUS SUMATRIPTAN,HEMICRANIA CONTINUA,MIGRAINE,PREVALENCE,ERGOTAMINE,MANAGEMENT,SYMPTOMS,FEATURES,DISEASE,ONSET}},
  language     = {{eng}},
  number       = {{1}},
  pages        = {{109--113}},
  title        = {{Medication-overuse headache in patients with cluster headache}},
  url          = {{http://doi.org/10.1212/01.wnl.0000223332.35936.6e}},
  volume       = {{67}},
  year         = {{2006}},
}
Altmetric
View in Altmetric
Web of Science
Times cited: